Yuhan (Korea) Today
| 000100 Stock | 134,000 2,000 1.47% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Yuhan is trading at 134000.00 as of the 19th of January 2025, a 1.47% down since the beginning of the trading day. The stock's open price was 136000.0. Yuhan has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 19th of January 2025. Click here to learn more.
Moving together with Yuhan Stock
| 0.61 | 005935 | Samsung Electronics | PairCorr |
| 0.68 | 005930 | Samsung Electronics | PairCorr |
| 0.68 | 000660 | SK Hynix Earnings Call This Week | PairCorr |
| 0.74 | 207940 | Samsung Biologics Earnings Call This Week | PairCorr |
| 0.62 | 051915 | LG Chem | PairCorr |
Moving against Yuhan Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Yuhan Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Yuhan's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Yuhan or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Yuhan (000100) is traded on Korea Stock Exchange in Korea and employs 10 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 3.67 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Yuhan's market, we take the total number of its shares issued and multiply it by Yuhan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Yuhan operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 70.4 M outstanding shares.
Yuhan generates positive cash flow from operations, but has no cash available
Check Yuhan Probability Of Bankruptcy
Ownership AllocationYuhan retains a total of 70.4 Million outstanding shares. Yuhan owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Yuhan Ownership Details
Yuhan Risk Profiles
Although Yuhan's alpha and beta are two of the key measurements used to evaluate Yuhan's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.4 | |||
| Standard Deviation | 3.16 | |||
| Variance | 9.98 | |||
| Risk Adjusted Performance | (0.06) |
Yuhan Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Yuhan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Yuhan Corporate Management
Elected by the shareholders, the Yuhan's board of directors comprises two types of representatives: Yuhan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Yuhan. The board's role is to monitor Yuhan's management team and ensure that shareholders' interests are well served. Yuhan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Yuhan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JungMan Ha | Managing Director | Profile | |
| Su MD | MD Institute | Profile | |
| DukHyun Kang | MD Department | Profile | |
| EunShik Kim | Managing Tft | Profile | |
| HyeonYun Shin | MD Department | Profile | |
| JongHong Lee | Managing TFT | Profile | |
| BokKyu Yoon | MD Department | Profile |
Other Information on Investing in Yuhan Stock
Yuhan financial ratios help investors to determine whether Yuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yuhan with respect to the benefits of owning Yuhan security.